Russells Hall Hospital

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Heart failure3 trials
• Childhood cancers2 trials
• Ulcerative colitis2 trials
• Aortic stenosis1 trial
• Atopic dermatitis (eczema)1 trial
• Chronic kidney disease1 trial
• High blood pressure1 trial
• Multiple myeloma1 trial
• Myeloproliferative neoplasms1 trial
• Prostate cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 36 trials
• Phase 2/32 trials
• Phase 41 trial

Status

• Recruiting6 trials
• Active, not recruiting4 trials
• Completed2 trials

Lead sponsor

• Alimentiv Inc.1 trial
• Amgen1 trial
• Biotronik SE & Co. KG1 trial
• Boehringer Ingelheim1 trial
• Cambridge University Hospitals NHS Foundation Trust1 trial
• and 7 more

Running trials

• Recruiting

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  NCT06736574· Phase 3· Cytokinetics· Source

  Contact: Cytokinetics MD

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  The "Global Paradise System" Registry

  NCT05027685· ReCor Medical, Inc.· Source

  Contact: Helen Reeve-Stoffer, PhD

• Recruiting

  The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

  NCT04204915· University of Leicester· Source

  Contact: Craig Barr

• Recruiting

  MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

  NCT04116502· Phase 3· University of Birmingham· Source

  Contact: Natalia Morelli

• Active, not recruiting

  Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

  NCT03366545· Biotronik SE & Co. KG· Source

• Recruiting

  The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

  NCT03562169· Phase 3· University of Leeds· Source

  Contact: Rupert Hipkins

• Recruiting

  Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

  NCT03150576· Phase 2/3· Cambridge University Hospitals NHS Foundation Trust· Source

  Contact: Devanshi Tripathi (principal investigator)

• Active, not recruiting

  Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

  NCT00268476· Phase 2/3· Medical Research Council· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure2 recruiting
• Aortic stenosis1 recruiting
• Childhood cancers1 recruiting
• Multiple myeloma1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Triple-negative breast cancer1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source

• Completed

  Determination of the Optimal Treatment Target in Ulcerative Colitis

  NCT04259138· Phase 4· Alimentiv Inc.· Source